ImCORE Germline Genomics initiative - iGGi
An international project aiming to establish the role of germline DNA variation in determining the efficacy and toxicity of cancer immunotherapy. We analyze the DNA of patients undergoing immunotherapy to identify biomarkers that can help predict the efficacy and toxicity of these treatments. An improved understanding of the genome represents a key step towards optimizing personalized oncology treatment.






